The Daily Caller Reports the pharmaceutical giant behind the painkiller OxyContin revealed it cut its entire remaining sales team in a shift away from opioids. Purdue Pharma announced the changes Tuesday, which will effectively end any contact the company has with medical providers regarding their medications. The company says that while it will still manufacture opioid-based medications, it is shifting primary focus to research and development into medications aimed at treating cancer and central nervous system disorders. Get free legal news daily from News.law
The White House announced a new proposal today for policies that respond to the opioid addiction crisis, including possibly imposing the death penalty for those charged with dealing drugs.
Jesselyn McCurdy, deputy director of the American Civil Liberties Union Washington Legislative Office, had the following reaction:
“The opioid crisis is a serious problem that requires a serious solution. But the draconian law enforcement provisions included in this proposal are unconstitutional and absurd.
“Drug trafficking is not an offense for which someone can receive the death penalty. The Supreme Court has repeatedly and consistently rejected the use of the death penalty in cases where there has been no murder by the convicted individual.
“This approach is also disturbingly reminiscent of the war on drugs, which set back American drug policy decades, and codified harm to black and brown people — laws we have just begun to reverse. And like the war on drugs — with a focus on extreme punishments instead of the root causes of drug use and no provisions to address racial disparities — the White House’s proposal will almost certainly fail to solve the actual crisis facing the country.
“The administration has, once again, put out a potentially disastrous and ill-thought-out policy proposal into our national discussion. The idea of executing people who sell drugs is ineffective, and lawmakers on both sides of the aisle understand that.”
This statement can be viewed online here: